178 related articles for article (PubMed ID: 16455914)
1. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.
Quint WG; Pagliusi SR; Lelie N; de Villiers EM; Wheeler CM;
J Clin Microbiol; 2006 Feb; 44(2):571-9. PubMed ID: 16455914
[TBL] [Abstract][Full Text] [Related]
2. Global proficiency study of human papillomavirus genotyping.
Eklund C; Zhou T; Dillner J;
J Clin Microbiol; 2010 Nov; 48(11):4147-55. PubMed ID: 20844222
[TBL] [Abstract][Full Text] [Related]
3. Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study.
Eklund C; Forslund O; Wallin KL; Dillner J
J Clin Microbiol; 2014 Feb; 52(2):449-59. PubMed ID: 24478473
[TBL] [Abstract][Full Text] [Related]
4. Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies.
Eklund C; Forslund O; Wallin KL; Dillner J
J Clin Virol; 2018 Apr; 101():74-85. PubMed ID: 29433017
[TBL] [Abstract][Full Text] [Related]
5. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology.
Eklund C; Forslund O; Wallin KL; Zhou T; Dillner J;
J Clin Microbiol; 2012 Jul; 50(7):2289-98. PubMed ID: 22535980
[TBL] [Abstract][Full Text] [Related]
6. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA.
Wilkinson DE; Baylis SA; Padley D; Heath AB; Ferguson M; Pagliusi SR; Quint WG; Wheeler CM;
Int J Cancer; 2010 Jun; 126(12):2969-83. PubMed ID: 19904756
[TBL] [Abstract][Full Text] [Related]
7. Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses.
Ferguson M; Heath A; Johnes S; Pagliusi S; Dillner J;
Int J Cancer; 2006 Mar; 118(6):1508-14. PubMed ID: 16184553
[TBL] [Abstract][Full Text] [Related]
8. External quality assessment for human papillomavirus 16/18 DNA detection and genotyping in Shanghai, China.
Wang X; Liu F; Jiang L; Bao Y; Xiao Y; Wang H
Clin Chem Lab Med; 2017 Feb; 55(2):195-202. PubMed ID: 27816947
[TBL] [Abstract][Full Text] [Related]
9. Proficiency test for human papillomavirus genotyping in china.
Zhang R; Huang J; Wang P; Sun Y; Zhang K; Xie J; Gao S; Wang L; Li J
Intervirology; 2013; 56(5):295-301. PubMed ID: 23838312
[TBL] [Abstract][Full Text] [Related]
10. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.
Jacobs MV; Snijders PJ; Voorhorst FJ; Dillner J; Forslund O; Johansson B; von Knebel Doeberitz M; Meijer CJ; Meyer T; Nindl I; Pfister H; Stockfleth E; Strand A; Wadell G; Walboomers JM
J Clin Pathol; 1999 Jul; 52(7):498-503. PubMed ID: 10605401
[TBL] [Abstract][Full Text] [Related]
11. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
12. Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format.
Kornegay JR; Shepard AP; Hankins C; Franco E; Lapointe N; Richardson H; Coutleé F;
J Clin Microbiol; 2001 Oct; 39(10):3530-6. PubMed ID: 11574568
[TBL] [Abstract][Full Text] [Related]
13. Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update.
Pagliusi SR; Dillner J; Pawlita M; Quint WG; Wheeler CM; Ferguson M
Vaccine; 2006 Aug; 24 Suppl 3():S3/193-200. PubMed ID: 16950007
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
15. Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study.
Arroyo Mühr LS; Eklund C; Lagheden C; Forslund O; Robertsson KD; Dillner J
J Clin Virol; 2022 Sep; 154():105237. PubMed ID: 35820294
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
[TBL] [Abstract][Full Text] [Related]
17. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
Carozzi F; Bisanzi S; Sani C; Zappa M; Cecchini S; Ciatto S; Confortini M
J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
Sandri MT; Lentati P; Benini E; Dell'Orto P; Zorzino L; Carozzi FM; Maisonneuve P; Passerini R; Salvatici M; Casadio C; Boveri S; Sideri M
J Clin Microbiol; 2006 Jun; 44(6):2141-6. PubMed ID: 16757611
[TBL] [Abstract][Full Text] [Related]
20. International collaborative proficiency study of Human Papillomavirus type 16 serology.
Eklund C; Unger ER; Nardelli-Haefliger D; Zhou T; Dillner J
Vaccine; 2012 Jan; 30(2):294-9. PubMed ID: 22079074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
